Gemtuzumab ozogamicin exposure and portal fibrosis

Pediatr Blood Cancer. 2005 Jul;45(1):82-3. doi: 10.1002/pbc.20333.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aminoglycosides / adverse effects*
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Chemical and Drug Induced Liver Injury*
  • Child
  • Child, Preschool
  • Female
  • Fibrosis
  • Gemtuzumab
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Male
  • Portal Vein / pathology*
  • Recurrence

Substances

  • Aminoglycosides
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Gemtuzumab